Skip to main content
. 2021 Jun 7;595(7866):278–282. doi: 10.1038/s41586-021-03676-z

Extended Data Fig. 10. Binding and neutralization of sarbecoviruses by nanomouse nanobodies and gating strategy for nanomouse and wild-type B cells.

Extended Data Fig. 10

a, Neutralization using trivalent Nb56 and Nb12, and bivalent Nb30, against pseudoviruses carrying SARS-CoV (left) or bat coronavirus WIV16 (right) spikes. Data are representative of two independent experiments and the error bars are mean ± s.d. of triplicates. b, BLI analysis of trivalent Nb56 and Nb12, and bivalent Nb30, binding to immobilized RBD from SARS-CoV-2 (left), SARS-CoV (middle) and bat coronavirus WIV16 (right). Equilibrium (KD) constants are provided. c, IC50 (pM) values for neutralization in culture assays, showing the sensitivity of HIV-1 and VSV pseudotyped viruses containing 13 sarbecoviral spike proteins. d, Analysis of bone marrow (top) or splenic (bottom) B cells was done by gating lymphocytes (first plot), avoiding aggregates (plots 2 and 3), B220+apoptotic gaiting (plot 4), and visualization with cell-surface makers as indicated (plots 5 and 6).